Wave life sciences to highlight rna base editing modality and alpha-1 antitrypsin deficiency program at upcoming scientific and industry meetings

Presentation at opt 2022 to highlight aatd program, including reduction of liver aggregates with repeat aimer dosing out to 19 weeks

WVE Ratings Summary

WVE Quant Ranking